Soen S - Search Results

1

Drug utilization pattern of romosozumab and other osteoporosis treatments in Japan, 2019-2021.

Soen S, Wang A, Hamaya E, Chien HC, Lin TC. Soen S, et al. J Bone Miner Metab. 2024 Nov;42(6):653-667. doi: 10.1007/s00774-024-01530-6. Epub 2024 Jul 10. J Bone Miner Metab. 2024. PMID: 38987505 Free PMC article.

2

[Daily practice using the guidelines for prevention and treatment of osteoporosis. The effects of anti-TNF therapy on bone and joint manifestations in rheumatoid arthritis].

Soen S. Soen S. Clin Calcium. 2008 Aug;18(8):1169-75. Clin Calcium. 2008. PMID: 18677056 Review. Japanese.

3

[The region of orthopaedic surgery and rheumatology].

Soen S. Soen S. Nihon Rinsho. 2011 Jun;69(6):1057-60. Nihon Rinsho. 2011. PMID: 21688627 Review. Japanese.

4

Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies.

Takeuchi T, Soen S, Ishiguro N, Yamanaka H, Tanaka S, Kobayashi M, Okubo N, Nitta T, Tanaka Y. Takeuchi T, et al. Among authors: soen s. Mod Rheumatol. 2021 Jan;31(1):34-41. doi: 10.1080/14397595.2019.1703484. Epub 2020 Jan 9. Mod Rheumatol. 2021. PMID: 31826682 Free article. Clinical Trial.

5

Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association.

Suzuki M, Nishida K, Soen S, Oda H, Inoue H, Kaneko A, Takagishi K, Tanaka T, Matsubara T, Mitsugi N, Mochida Y, Momohara S, Mori T, Suguro T. Suzuki M, et al. Among authors: soen s. J Orthop Sci. 2011 Nov;16(6):778-84. doi: 10.1007/s00776-011-0142-3. Epub 2011 Aug 27. J Orthop Sci. 2011. PMID: 21874335

6

Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis.

Soen S, Kishimoto H, Hagino H, Sone T, Ohishi H, Fujimoto T, Sasaki E, Tanaka S, Sugimoto T. Soen S, et al. J Bone Miner Metab. 2020 Jan;38(1):86-98. doi: 10.1007/s00774-019-01031-x. Epub 2019 Aug 16. J Bone Miner Metab. 2020. PMID: 31420748 Clinical Trial.

7

Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study.

Soen S, Yamamoto K, Takeuchi T, Tanaka Y, Tanaka S, Ito M, Nakano T, Hagino H, Hirakawa A, Matsumoto T. Soen S, et al. J Bone Miner Metab. 2020 Jul;38(4):511-521. doi: 10.1007/s00774-019-01077-x. Epub 2020 Jan 22. J Bone Miner Metab. 2020. PMID: 31970477 Clinical Trial.

8

Management manual for cancer treatment-induced bone loss (CTIBL): position statement of the JSBMR.

Fukumoto S, Soen S, Taguchi T, Ishikawa T, Matsushima H, Terauchi M, Horie S, Yoneda T, Sugimoto T, Matsumoto T; Subcommittee for CTIBL in the JSBMR. Fukumoto S, et al. Among authors: soen s. J Bone Miner Metab. 2020 Mar;38(2):141-144. doi: 10.1007/s00774-020-01087-0. Epub 2020 Feb 4. J Bone Miner Metab. 2020. PMID: 32020289

9

Efficacy of once-weekly teriparatide in patients with glucocorticoid-induced osteoporosis: the TOWER-GO study.

Tanaka I, Tanaka Y, Soen S, Oshima H. Tanaka I, et al. Among authors: soen s. J Bone Miner Metab. 2021 May;39(3):446-455. doi: 10.1007/s00774-020-01171-5. Epub 2020 Nov 19. J Bone Miner Metab. 2021. PMID: 33211212 Clinical Trial.

10

Family caregiver burden of patients with osteoporotic fracture in Japan.

Soen S, Usuba K, Crawford B, Adachi K. Soen S, et al. J Bone Miner Metab. 2021 Jul;39(4):612-622. doi: 10.1007/s00774-020-01197-9. Epub 2021 Feb 17. J Bone Miner Metab. 2021. PMID: 33595773

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters